[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
November 25, 2013

Methicillin-Resistant Staphylococcus aureusWhere Is It Coming From and Where Is It Going?

Author Affiliations
  • 1Division of Infectious Diseases, College of Physicians and Surgeons, Columbia University, New York, New York
JAMA Intern Med. 2013;173(21):1978-1979. doi:10.1001/jamainternmed.2013.8277

Despite the availability of effective preventative and therapeutic strategies, methicillin-resistant Staphylococcus aureus (MRSA) remains a major cause of health care–associated and, more recently, community-acquired infections. Since the introduction of methicillin in 1959, epidemics due to different clones of MRSA have occurred in diverse geographic regions.1 The result has been the persistence of MRSA as an important pathogen worldwide.

First Page Preview View Large
First page PDF preview
First page PDF preview